360 related articles for article (PubMed ID: 3740078)
1. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia.
Buyon JP; Cronstein BN; Morris M; Tanner M; Weissmann G
Am J Med; 1986 Aug; 81(2):194-200. PubMed ID: 3740078
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
[TBL] [Abstract][Full Text] [Related]
3. Serum urate, complement 3 and pre-eclampsia in patients with systemic lupus erythematosus.
Lao TT; Leung BF
Eur J Obstet Gynecol Reprod Biol; 1988 Sep; 29(1):7-13. PubMed ID: 3224745
[TBL] [Abstract][Full Text] [Related]
4. Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group.
Ricker DM; Hebert LA; Rohde R; Sedmak DD; Lewis EJ; Clough JD
Am J Kidney Dis; 1991 Dec; 18(6):678-85. PubMed ID: 1962653
[TBL] [Abstract][Full Text] [Related]
5. The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus.
Grennan DM; Moseley A; Sloane D; Pumphrey R; Dick WC; Buchanan WW
Aust N Z J Med; 1977 Dec; 7(6):625-9. PubMed ID: 306817
[TBL] [Abstract][Full Text] [Related]
6. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
[TBL] [Abstract][Full Text] [Related]
7. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
8. Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy.
Abramson SB; Buyon JP
Am J Reprod Immunol; 1992; 28(3-4):183-7. PubMed ID: 1285875
[TBL] [Abstract][Full Text] [Related]
9. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Ho A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels.
Singsen BH; Bernstein BH; King KK; Hanson V
J Pediatr; 1976 Sep; 89(3):358-69. PubMed ID: 956959
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
12. [Serum free light chains for monitoring systemic lupus erythematosus activity].
Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
[TBL] [Abstract][Full Text] [Related]
13. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
[TBL] [Abstract][Full Text] [Related]
14. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
15. Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies.
Radin M; Cecchi I; Crisafulli F; Klumb EM; de Jesús GR; Lacerda MI; Saavedra MÁ; Reyes-Navarro GV; Iaccarino L; Larosa M; Moroni G; Tamborini F; Roccatello D; Andreoli L; Sciascia S; Chighizola CB
Autoimmun Rev; 2023 Dec; 22(12):103467. PubMed ID: 37852515
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.
Li H; Lin S; Yang S; Chen L; Zheng X
Clin Rheumatol; 2015 Mar; 34(3):471-7. PubMed ID: 25597615
[TBL] [Abstract][Full Text] [Related]
17. Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus.
Lehman TJ; Hanson V; Singsen BH; Kornreich HK; Bernstein B; King KK
Arthritis Rheum; 1979 Sep; 22(9):954-8. PubMed ID: 314291
[TBL] [Abstract][Full Text] [Related]
18. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
[TBL] [Abstract][Full Text] [Related]
19. [Systemic lupus erythematosus and pregnancy. Clinical aspects, serology and management].
Runge HM; Röther E; Kerl J; DuBois A; Quaas L; Hillemanns HG
Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):560-8. PubMed ID: 2391023
[TBL] [Abstract][Full Text] [Related]
20. Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient.
Lockshin MD; Harpel PC; Druzin ML; Becker CG; Klein RF; Watson RM; Elkon KB; Reinitz E
Arthritis Rheum; 1985 Jan; 28(1):58-66. PubMed ID: 3917671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
